Psychopharmacology in the Treatment of Patients with Cardiovascular Disease
Authors:
- 1 June 2016
- book chapter
- Published by Springer Nature
- p. 1043-1059
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Meta-Analysis of Selective Serotonin Reuptake Inhibitor–Associated QTc ProlongationThe Journal of Clinical Psychiatry, 2014
- QT interval and antidepressant use: a cross sectional study of electronic health recordsBMJ, 2013
- The spectrum of acute heart failure after venlafaxine overdoseClinical Toxicology, 2013
- QTc Prolongation, Torsades de Pointes, and Psychotropic MedicationsPsychosomatics, 2013
- IloperidoneThe Journal of Clinical Psychiatry, 2011
- Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychoticInternational Journal Of Clinical Practice, 2009
- Depression and Late Mortality After Myocardial Infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) StudyPsychosomatic Medicine, 2004
- Consensus Development Conference on Antipsychotic Drugs and Obesity and DiabetesDiabetes Care, 2004
- Bupropion poisoning: a case seriesMedical Journal of Australia, 2003
- Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agentsThe American Journal of Medicine, 2000